Charleston Laboratories, Daiichi Sankyo deal

Charleston and Daiichi Sankyo partnered to develop and commercialize Charleston’s fixed-dose combination hydrocodone products to treat pain and opioid-induced nausea and vomiting (OINV) in the U.S. Th...